|
US8183339B1
(en)
|
1999-10-12 |
2012-05-22 |
Xigen S.A. |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
US20040082509A1
(en)
|
1999-10-12 |
2004-04-29 |
Christophe Bonny |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
CA2414076A1
(en)
|
2000-06-08 |
2001-12-13 |
La Jolla Pharmaceutical Company |
Multivalent platform molecules comprising high molecular weight polyethylene oxide
|
|
US20040248158A1
(en)
*
|
2003-01-28 |
2004-12-09 |
Loughran Thomas P |
Differentially expressed genes in large granular lymphocyte leukemia
|
|
US7342095B2
(en)
|
2003-02-20 |
2008-03-11 |
University Of South Florida |
Peptidomimetic inhibitors of STAT activity and uses thereof
|
|
US7189694B2
(en)
*
|
2003-04-18 |
2007-03-13 |
University Of Florida Research Foundation, Inc. |
Inhibitors of autophosphorylation protein kinases
|
|
CA2535762A1
(en)
*
|
2003-08-13 |
2005-03-17 |
University Of South Florida |
Methods for inhibiting tumor cell proliferation
|
|
US8227434B1
(en)
|
2003-11-04 |
2012-07-24 |
H. Lee Moffitt Cancer Center & Research Institute, Inc. |
Materials and methods for treating oncological disorders
|
|
US20050288365A1
(en)
*
|
2004-01-06 |
2005-12-29 |
Heidi Kay |
Platinum complexes and methods for inhibiting tumor cell proliferation
|
|
AU2005214979B2
(en)
|
2004-02-17 |
2009-09-10 |
The Uab Research Foundation |
Cytotoxin compound and method of isolation
|
|
US8669376B2
(en)
|
2004-02-17 |
2014-03-11 |
University Of South Florida |
Cytotoxin compounds and methods of isolation
|
|
US8080517B2
(en)
|
2005-09-12 |
2011-12-20 |
Xigen Sa |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
WO2007031098A1
(en)
|
2005-09-12 |
2007-03-22 |
Xigen S.A. |
Cell-permeable peptide inhibitors of the jnk signal transduction pathway
|
|
WO2007047623A2
(en)
*
|
2005-10-14 |
2007-04-26 |
University Of South Florida |
Methods of inhibiting cell growth and methods of enhancing radiation responses
|
|
DE102006040647A1
(de)
*
|
2006-08-30 |
2008-03-13 |
Robert Bosch Gmbh |
Handwerkzeugmaschine
|
|
WO2008079945A2
(en)
*
|
2006-12-20 |
2008-07-03 |
University Of South Florida |
Rock inhibitors and uses thereof
|
|
WO2009012143A2
(en)
*
|
2007-07-13 |
2009-01-22 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Virus derived antimicrobial peptides
|
|
WO2009143864A1
(en)
|
2008-05-30 |
2009-12-03 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases
|
|
WO2009143865A1
(en)
|
2008-05-30 |
2009-12-03 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
|
US8673910B2
(en)
*
|
2008-06-30 |
2014-03-18 |
H. Lee Moffitt Cancer Center And Research Institute |
Proteasome inhibitors for selectively inducing apoptosis in cancer cells
|
|
WO2010011666A2
(en)
*
|
2008-07-21 |
2010-01-28 |
University Of South Florida |
Indoline scaffold shp-2 inhibitors and cancer treatment method
|
|
CN102215860A
(zh)
*
|
2008-08-05 |
2011-10-12 |
南佛罗里达大学 |
治疗认知损害的方法
|
|
US9132168B2
(en)
|
2008-08-05 |
2015-09-15 |
University Of South Florida |
Methods of treating cognitive impairment
|
|
WO2010072228A1
(en)
*
|
2008-12-22 |
2010-07-01 |
Xigen S.A. |
Novel transporter constructs and transporter cargo conjugate molecules
|
|
CA2768149A1
(en)
*
|
2009-07-14 |
2011-01-20 |
Lucia Irene Gonzalez |
Stereoisomer peptides and their polymer conjugates for hiv disease
|
|
US9221808B2
(en)
|
2010-04-16 |
2015-12-29 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinase (ROCK) and methods of use
|
|
WO2011160653A1
(en)
|
2010-06-21 |
2011-12-29 |
Xigen S.A. |
Novel jnk inhibitor molecules
|
|
AU2010362444B2
(en)
|
2010-10-14 |
2015-08-06 |
Xigen Inflammation Ltd. |
Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases
|
|
WO2012135697A2
(en)
|
2011-03-30 |
2012-10-04 |
H. Lee Moffitt Cancer Center & Research Institute Inc. |
Novel rho kinase inhibitors and methods of use
|
|
WO2013091670A1
(en)
|
2011-12-21 |
2013-06-27 |
Xigen S.A. |
Novel jnk inhibitor molecules for treatment of various diseases
|
|
US9409868B2
(en)
|
2012-01-24 |
2016-08-09 |
H. Lee Moffin Cancer Center and Research Institute, Inc. |
Inhibitors of rho associated protein kinases (ROCK) and methods of use
|
|
EP2822926A4
(en)
|
2012-03-07 |
2015-11-04 |
H Lee Moffitt Cancer Ct & Res |
SELECTIVE HISTON DEACTY LASE-6 HEMMER
|
|
US10098967B2
(en)
|
2012-12-03 |
2018-10-16 |
Ohio State Innovation Foundation |
Self-assembly of therapeutic agent-peptide nanostructures
|
|
US10253099B2
(en)
|
2012-12-05 |
2019-04-09 |
Ruprecht-Karls-Universität Heidelberg |
Conjugates of proteins and multivalent cell-penetrating peptides and their uses
|
|
PL2970463T3
(pl)
*
|
2013-03-13 |
2018-04-30 |
Biocrine Ab |
Sposoby leczenia i/lub ograniczania rozwoju cukrzycy
|
|
WO2014206427A1
(en)
|
2013-06-26 |
2014-12-31 |
Xigen Inflammation Ltd. |
New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
|
EA201501080A1
(ru)
|
2013-06-26 |
2016-07-29 |
Ксижен Инфлемейшн Лтд. |
Новое применение обладающих способностью проникать в клетку пептидных ингибиторов пути трансдукции сигнала jnk для лечения различных заболеваний
|
|
WO2015197097A1
(en)
|
2014-06-26 |
2015-12-30 |
Xigen Inflammation Ltd. |
New use for jnk inhibitor molecules for treatment of various diseases
|
|
WO2015021149A1
(en)
|
2013-08-06 |
2015-02-12 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibitors of ack1/tnk2 tyrosine kinase
|
|
WO2015025323A1
(en)
|
2013-08-21 |
2015-02-26 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Treatment of mood and stress related disorders
|
|
US10626178B2
(en)
|
2013-08-21 |
2020-04-21 |
Raz Yirmiya |
Treatment of mood and stress related disorders
|
|
JP2017503833A
(ja)
|
2014-01-23 |
2017-02-02 |
エイチ リー モフィット キャンサー センター アンド リサーチ インスティテュート インコーポレイテッド |
イカリイン誘導体
|
|
WO2015112904A1
(en)
|
2014-01-24 |
2015-07-30 |
University Of Florida Research Foundation, Inc. |
Socs mimetics for the treatment of diseases
|
|
US10463684B2
(en)
|
2014-01-29 |
2019-11-05 |
Board Of Regents, The Uneversety Of Texas System |
Nucleobase analogue derivatives and their applications
|
|
US10197575B2
(en)
|
2014-03-31 |
2019-02-05 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Stabilized peptoid-peptide hybrids and uses thereof
|
|
WO2015157162A1
(en)
|
2014-04-06 |
2015-10-15 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Histone deacetylase as a modulator of pdl1 expression and activity
|
|
ES2980788T3
(es)
|
2014-04-10 |
2024-10-03 |
H Lee Moffitt Cancer Ct & Res |
Expansión mejorada de linfocitos infiltrantes de tumores para terapia celular adoptiva
|
|
PT3149025T
(pt)
|
2014-05-21 |
2019-08-01 |
Entrada Therapeutics Inc |
Peptídeos penetrantes de células e métodos de fabrico e utilização dos mesmos
|
|
US10815276B2
(en)
|
2014-05-21 |
2020-10-27 |
Entrada Therapeutics, Inc. |
Cell penetrating peptides and methods of making and using thereof
|
|
WO2016033368A1
(en)
|
2014-08-27 |
2016-03-03 |
Ohio State Innovation Foundation |
Improved peptidyl calcineurin inhibitors
|
|
WO2016154586A1
(en)
|
2015-03-26 |
2016-09-29 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Toll-like receptor 2 ligands and methods of making and using thereof
|
|
AU2016258123A1
(en)
|
2015-05-06 |
2018-01-04 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Radiotherapeutic and companion imaging agents to target MC1R
|
|
US10995140B2
(en)
|
2015-06-05 |
2021-05-04 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
GM-CSF/CD40L vaccine and checkpoint inhibitor combination therapy
|
|
EP3328496A4
(en)
|
2015-08-02 |
2018-12-19 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibitors of ack1/tnk2 tyrosine kinase
|
|
JP6978420B2
(ja)
|
2015-09-17 |
2021-12-08 |
オハイオ・ステート・イノヴェーション・ファウンデーション |
カルボラン化合物及びその使用方法
|
|
WO2017066428A1
(en)
|
2015-10-13 |
2017-04-20 |
H. Lee Moffitt Cancer Center & Research Institute, Inc. |
Brd4-kinase inhibitors as cancer therapeutics
|
|
EP3387133B1
(en)
|
2015-12-09 |
2021-11-17 |
Vanderbilt University |
Biosynthesis of everninomicin analogs in micromonospora carbonacea var aurantiaca
|
|
WO2017156527A1
(en)
|
2016-03-11 |
2017-09-14 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Aurora kinase and janus kinase inhibitors for prevention of graft versus host disease
|
|
CN109153644B
(zh)
|
2016-03-16 |
2022-10-21 |
H·李·莫菲特癌症中心研究有限公司 |
用以增强效应t细胞功能的针对cereblon的小分子
|
|
US10426843B2
(en)
|
2016-05-04 |
2019-10-01 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer
|
|
CA3043464A1
(en)
|
2016-11-09 |
2018-05-17 |
Ohio State Innovation Foundation |
Di-sulfide containing cell penetrating peptides and methods of making and using thereof
|
|
US10913773B2
(en)
|
2016-11-22 |
2021-02-09 |
Ohio State Innovation Foundation |
Bicyclic peptidyl inhibitor of tumor necrosis factor-alpha
|
|
TW202500573A
(zh)
|
2016-11-22 |
2025-01-01 |
俄亥俄州立創新基金會 |
細胞穿透肽序列
|
|
US11352394B2
(en)
|
2016-11-22 |
2022-06-07 |
Ohio State Innovation Foundation |
Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereof
|
|
US11583525B2
(en)
|
2017-06-06 |
2023-02-21 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Geranylgeranyltransferase I inhibitor for treatment of a PTEN defective cancer
|
|
US11339192B2
(en)
|
2017-10-04 |
2022-05-24 |
Ohio State Innovation Foundation |
Bicyclic peptidyl inhibitors
|
|
CN111447941B
(zh)
|
2017-10-27 |
2023-10-31 |
俄亥俄州国家创新基金会 |
用于细胞内递送装订肽的多肽缀合物
|
|
US11576946B2
(en)
|
2018-01-29 |
2023-02-14 |
Ohio State Innovation Foundation |
Peptidyl inhibitors of calcineurin-NFAT interaction
|
|
EP3746105A4
(en)
|
2018-01-29 |
2022-05-18 |
Ohio State Innovation Foundation |
CYCLIC PEPTIDYLIN HIBITORS OF THE CAL-PDZ-BINDING DOMAIN
|
|
WO2019165183A1
(en)
|
2018-02-22 |
2019-08-29 |
Entrada Therapeutics, Inc. |
Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy
|
|
EP3787671A4
(en)
|
2018-05-04 |
2022-06-15 |
Ohio State Innovation Foundation |
NON-PEPTIDE CELL-PENETRATING MOTIFS
|
|
WO2019217682A1
(en)
|
2018-05-09 |
2019-11-14 |
Ohio State Innovation Foundation |
Cyclic cell-penetrating peptides with one or more hydrophobic residues
|
|
EP3820532A4
(en)
|
2018-07-11 |
2022-04-06 |
H. Lee Moffitt Cancer Center & Research Institute, Inc. |
DIMERE IMMUNOMODULATORY COMPOUNDS AGAINST CEREBLON-BASED MECHANISMS
|
|
US10898460B1
(en)
|
2018-07-20 |
2021-01-26 |
University Of South Florida |
Leishmania inhibitors
|
|
US11987568B2
(en)
|
2018-08-03 |
2024-05-21 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Allosteric inhibitor of WEE1 kinase
|
|
US12319685B2
(en)
|
2018-08-17 |
2025-06-03 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Small molecule pyrin-domain targeted NLRP3 inflammasome inhibitors
|
|
WO2020081918A2
(en)
|
2018-10-18 |
2020-04-23 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Βeta-catenin and b-cell lymphoma 9 (bcl9) inhibitors
|
|
WO2020081917A1
(en)
|
2018-10-18 |
2020-04-23 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Βeta-catenin and b-cell lymphoma 9 (bcl9) inhibitors
|
|
WO2020118179A1
(en)
|
2018-12-07 |
2020-06-11 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Peptidomimetic inhibitors of β-catenin/tcf protein–protein interaction
|
|
JP2023501385A
(ja)
|
2019-11-08 |
2023-01-18 |
ユニバーシティ オブ ピッツバーグ - オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション |
抗微生物ペプチドを含む組成物
|
|
EP4058032A4
(en)
|
2019-12-19 |
2024-01-10 |
Entrada Therapeutics, Inc. |
Compositions for delivery of antisense compounds
|
|
KR102811112B1
(ko)
|
2020-01-20 |
2025-05-21 |
삼성전자주식회사 |
매립형 공기청정장치
|
|
WO2021150928A1
(en)
|
2020-01-23 |
2021-07-29 |
University Of South Florida |
Prevention and treatment of effects of aging and age-associated disorders with ketone supplementation
|
|
US20230097866A1
(en)
|
2020-01-24 |
2023-03-30 |
Ohio State Innovation Foundation |
Bacterial topoisomerase inhibitors derived from isomannide
|
|
US20230190871A1
(en)
|
2020-05-20 |
2023-06-22 |
Sana Biotechnology, Inc. |
Methods and compositions for treatment of viral infections
|
|
WO2022036313A1
(en)
|
2020-08-14 |
2022-02-17 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Pyrimidinyl sulfonamides as inhibitors of ack1/tnk1 tyrosine kinase
|
|
US12630535B2
(en)
|
2020-08-14 |
2026-05-19 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibitors of ACK1/TNK2 tyrosine kinase
|
|
US12617787B2
(en)
|
2020-11-30 |
2026-05-05 |
Lee Moffitt Cancer Center and Research Institute, Inc. |
Merged scaffold TAF1 inhibitors
|
|
KR20240009393A
(ko)
|
2021-03-31 |
2024-01-22 |
엔트라다 테라퓨틱스, 인크. |
사이클릭 세포 침투 펩티드
|
|
US12371463B2
(en)
|
2021-04-20 |
2025-07-29 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Methods and compositions for treatment of antibiotic-resistant bacterial infections
|
|
IL308353A
(en)
|
2021-05-10 |
2024-01-01 |
Entrada Therapeutics Inc |
Compositions and methods for modulating tissue distribution of intracellular therapies
|
|
US20250051393A1
(en)
|
2021-05-10 |
2025-02-13 |
Entrada Therapeutics, Inc. |
Compositions and methods for modulating interferon regulatory factor-5 (irf-5) activity
|
|
JP2024518476A
(ja)
|
2021-05-10 |
2024-05-01 |
エントラーダ セラピューティクス,インコーポレイティド |
mRNAスプライシングを調節するための組成物及び方法
|
|
AU2022298774A1
(en)
|
2021-06-23 |
2023-12-14 |
Entrada Therapeutics, Inc. |
Antisense compounds and methods for targeting cug repeats
|
|
EP4395829A1
(en)
|
2021-09-01 |
2024-07-10 |
Entrada Therapeutics, Inc. |
Compounds and methods for skipping exon 44 in duchenne muscular dystrophy
|
|
WO2023219933A1
(en)
|
2022-05-09 |
2023-11-16 |
Entrada Therapeutics, Inc. |
Compositions and methods for delivery of nucleic acid therapeutics
|
|
EP4555089A2
(en)
|
2022-07-15 |
2025-05-21 |
Entrada Therapeutics, Inc. |
Hybrid oligonucleotides
|
|
WO2024073042A1
(en)
|
2022-09-30 |
2024-04-04 |
Entrada Therapeutics, Inc. |
Ocular delivery of therapeutic agents
|
|
CN120359232A
(zh)
*
|
2022-12-01 |
2025-07-22 |
海维尔私人有限公司 |
新型肽偶联物
|
|
CN121772940A
(zh)
|
2023-08-17 |
2026-03-31 |
恩特拉达治疗学股份有限公司 |
寡核苷酸的细胞内靶向
|
|
WO2025038901A1
(en)
|
2023-08-17 |
2025-02-20 |
Entrada Therapeutics, Inc. |
Cyclic peptides for delivering therapeutics
|
|
IL327379A
(en)
|
2023-09-26 |
2026-05-01 |
Entrada Therapeutics Inc |
Compounds and methods for skipping exon 50 in Duchenne muscular dystrophy
|
|
WO2026151958A1
(en)
|
2025-01-10 |
2026-07-16 |
Entrada Therapeutics, Inc. |
Compounds and methods for skipping exon 51 in duchenne muscular dystrophy
|